PRECLINICAL SINGLE-CELL PROFILING
Xenium STAMP single-cell profiling for preclinical studies
Need to resolve how individual cell populations respond to your drug across conditions and time points?
Explicyte applies STAMP (Single-cell Transcriptomics Analysis and Multimodal Profiling), an imaging-based workflow published in Cell, to fixed dissociated cells. Cells are immobilized directly onto Xenium slides and profiled for targeted gene expression at single-cell resolution, without a sequencing step. This enables high-cell-count, multi-condition studies with the mechanistic depth of single-cell transcriptomics.
Up to 48 conditions/run · ~5,000 genes · no sequencing
XENIUM STAMP
Add single-cell transcriptomic depth to functional cell assays
Functional assays tell you whether a drug produces a response. Xenium STAMP helps resolve which cells respond, how their abundance and state change, and which gene-expression programs accompany that response.
Up to 48 conditions within a single run
Two Xenium slides are processed within the same run, allowing multiple treatments, donors, concentrations or time points to be profiled together. This creates economies of scale while limiting inter-run variability.
~1 million cells per run for deep population coverage
High cell capture provides the depth needed to resolve immune and tumor-cell subsets, treatment-induced states, and rare populations within heterogeneous samples.
Transcriptomic depth without sequencing
Profile targeted gene expression at single-cell resolution, with focused panels or Xenium Prime 5K plus custom genes, then resolve differential expression and pathways within defined cell populations.
At a glance
Xenium STAMP: format and readouts
WORKFLOW
From functional assay to cell-resolved mechanism
PRECLINICAL APPLICATIONS
Use STAMP where functional readouts need deeper mechanistic resolution
CHOOSING THE RIGHT READOUT
Xenium STAMP, flow cytometry or scRNA-seq?
These approaches are complementary. Xenium STAMP is particularly useful when a defined biological question needs to be tested across many cells and experimental conditions, while Chromium X is better suited to broader transcriptomic discovery.
REPRESENTATIVE DATA
Representative Xenium STAMP data
FROM ASSAY TO INTERPRETATION
Why work with Explicyte for Xenium STAMP studies
Preclinical study design
Integrated functional & single-cell readouts
In-house biological interpretation
Paul Marteau, PharmD (study director), Imane Nafia, PhD (CSO), Loïc Cerf, MSc (COO), Alban Bessede, PhD (founder, CEO), Jean-Philippe Guégan, PhD (CTO)
Contact our team
Discuss your Xenium STAMP study
Tell us your model, cell type, treatment conditions, time points and the biological question you want to resolve. We'll help determine whether STAMP, flow cytometry, Chromium X — or a combination — is the best fit for your study.
XENIUM STAMP FAQ

